SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1475-7. doi: 10.1007/s00259-013-2484-x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Neoplasms / diagnostic imaging*
  • Neoplasms / metabolism
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Protein Binding
  • Radiopharmaceuticals / pharmacokinetics
  • Reference Standards

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18